Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)

NCT05844163 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT05844163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05844163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)
Lead sponsor
Beijing Tiantan Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
December 1, 2024
Enrollment
31,595 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unruptured intracranial aneurysm